I'm undecided between selling $ASML (-3,27%) or $MU (-3,8%) ; both seem to have gone up a lot. I think I should realize some profit or sell one outright, but which one?

ASML
Price
Discussão sobre ASML
Postos
645Strategy update: Why I include 12% MSCI Europe Momentum as a "midfield turbo"
Hello everyone,
I've taken another look at my portfolio. I currently have a mix of a solid All World (23%) foundation, a strong cash/gold reserve (28%) and some aggressive individual bets such as $IREN (-9,68%)
$HIMS (-3,93%) and $LMND (-2,85%) and $BTC (-1,18%) .
What I've been missing so far is the "strong midfield" - a component that is less risky than stock-picking but has more power than a standard European index.
My plan: I consistently shift profits from my individual stocks (as soon as they reach +100%) into the iShares MSCI Europe Momentum $IEFM (-1,25%) . Target weighting: 12 %.
Why exactly this ETF?
Instead of investing in the EuroStoxx 50 $CSSX5E (-0,98%) "old industrial dinosaurs", the momentum factor filters out the strongest players in Europe at the moment (e.g. $SIE (-0,84%)
$SAP (-0,6%)).
Regional diversification: My portfolio is very US and tech-heavy. With the momentum approach, I get the European elite on board, including Switzerland, the UK and Denmark (which are missing from the EuroStoxx!).
Automatic rebalancing: If trends shift (e.g. from pharma to defense or tech), the ETF adjusts every six months. I don't have to guess which sector will perform next.
The strategy: I use my "high-flyers" as a source. When stocks like $IREN (-9,68%) or $GOOGL reach their targets, I withdraw the stake and park it in the momentum ETF. In this way, I reduce my individual stock risk, but remain offensive in terms of the potential return.
The only watchpoint: Since I $NOVO B (-1,59%) and $ASML (-3,27%) as individual stocks, I make sure that the total weighting of these stocks in the ETF does not become a lump (limit: max. 8% per stock).
What do you think of the move? Would it be better to invest broadly in the Stoxx 50 $CSSX5E (-0,98%) or 600 $EXSA (-0,83%) or does the momentum factor make more sense for a growth strategy? 📈
Sold ASML and doubled down on UNH
Yesterday, I closed my position in $ASML for a 102% profit. While there might be some room for growth left this year, I’m becoming wary of the massive AI-related capital expenditures. I no longer feel comfortable holding at these levels.
Instead, I rotated those gains into my $UNH position, as a shift from Growth to Value. With the stock down roughly 20% recently, I saw a good entry point at $284. Having held $UNH since it crashed to $250, I view this dip as a good opportunity.
What do you think about this rotation? Is ASML getting too risky, or am I leaving money on the table?
Selling off without sense and reason
$ASML (-3,27%) From 1240 to 1190 within 70 minutes - and that at ASML...and above all: for no reason...and it keeps going down...that makes no sense! 🤔
Loss-makers out
Yesterday was a good day in the wake of the failed $ASML (-3,27%) trade was a good day to dump other stocks as well. There will probably be some buying today.
First of all, the trade on $SPGI (-1,27%) had to leave the portfolio.
Investment in semiconductors
Dear Community,
What has been $ASML (-3,27%) on everyone's lips. I sold before the figures and placed a small short, like many of you.
The short burst, the share price rose sharply - at first!
Now it is almost back to the prices before the figures. Many have used the good figures and the reaction to take profits.
I, too, am in a wait-and-see position, but have looked to the left and right and bought directly into $AVGO (-2,81%)
$TSM (-2,69%)
$AMAT (-3,48%)
$MU (-3,8%)
$LRCX (-3,81%) and even $ASML (-3,27%) invested.
Irritated?
After I $ASML (-3,27%) sold, I discovered an ETF $SEMI (-3,92%) that contains all these stocks and of course many more, which I like.
I am still convinced of ASML, but the price of the share is slowly becoming too high for me to be able to invest sensibly in other stocks. So I have decided to open a position of 435 shares in the ETF, as I continue to see high growth in the entire sector.
Even if it is not a presentation of a share, I hope that this idea of investing in the sector will be of interest to some of you.
Best regards 🐰 André
That's how it is
$ASML (-3,27%) Easy come, easy go. I'm staying in.
ASML - What's next?
Hello dear community,
What's going on with ASML right now is unbelievable. I bought the share during the last crash at around € 625 and since then the price has doubled - it's incredible.
I had expected ASML to report good figures today and at the same time thought that the market might still be disappointed and the share price would fall. Instead, the share price rose again today by around € 85. As this is slowly getting too hot for me, I have set a stop loss at € 1,200 to secure profits.
I am interested in your assessment:
Do you think ASML could still crack €1,400 or even €1,500, or is another setback imminent?
I look forward to your comments.
ASML Q4’25 EARNINGS HIGHLIGHTS
🔹 Net Sales: €9.72B (Est. €9.57B) 🟢; 5% YoY
🔹 EPS (basic): €7.35 (Est. €7.55) 🌕
🔹 Bookings: €13.16B (Est. €6.85B) 🟢
🔹 Gross Margin: 52.2% (Est. 51.9%) 🟢
🔹 FY Order Backlog: €38.8B (Est. €33.08B) 🟢
🔹 EUV sales: 14 systems (Est. 12.33) 🟢
🔸 New share buyback: up to €12B by Dec. 31, 2028
🔸 Plans to streamline Technology and IT organizations; plans ~1,700 job cuts (~4% of workforce)
FY Guide:
🔹 Sales: €34B to €39B (Est. €35.15B) 🟢; + 16% YoY
🔹 Gross Margin: 51% to 53% (Est. 52.9%) 🟡
Q1 Guide:
🔹 Net Sales: €8.2B to €8.9B (Est. €8.13B) 🟢
🔹 Gross Margin: 51% to 53% (Est. 52.5%) 🟡
🔹 R&D expenses: ~€1.2B (Est. €1.21B) 🟢
🔹 SG&A costs: ~€0.3B
Q4 Segment Performance:
🔹 Net system sales: €7.58B (Est. €7.44B) 🟢
🔹 Net service & field operation sales: €2.13B (Est. €2.11B) 🟢
🔹 Total lithography systems sold: 102 units (Est. 115.38) 🔴
🔹 ArFi sales: 37 (Est. 41.07) 🔴
🔹 ArFdry sales: 5 (Est. 7.79) 🔴
🔹 KrF sales: 29 (Est. 34.53) 🔴
🔹 I-Line sales: 17 (Est. 19.93) 🔴
Other Metrics:
🔹 Bookings: €13.16B; of which EUV €7.4B
🔹 Operating margin: 35.3%
🔹 Net system sales China share: 36%
2030 opportunity:
🔸 Annual revenue ~€44B to €60B
🔸 Gross margin ~56% to 60%
Financials:
🔹 Operating income: €3.43B (Est. €3.44B) 🔴
🔹 R&D expenses: €1.26B (Est. €1.21B) 🔴
🔹 Net income: €2.84B (Est. €2.91B) 🔴; +34% Q/Q
🔹 Cash and other: €13.32B (Est. €5.85B) 🟢
Capital Return:
🔹 FY dividend per share: €7.50
🔹 Final dividend per share: €2.70
🔹 Interim dividend per share: €1.60 (payable Feb. 18, 2026)
🔹 Q4 share repurchases: ~€1.7B (2022–2025 program); total €7.6B repurchased (program completed Dec. 2025)
🔹 New share buyback: up to €12B by Dec. 31, 2028 (expects up to ~2M shares for employee plans; intends to cancel the remainder)
Commentary:
🔸 “In the last months, many of our customers have shared a notably more positive assessment of the medium-term market situation, primarily based on more robust expectations of the sustainability of AI-related demand.”
🔸 “This is reflected in a marked step-up in their medium-term capacity plans and in our record order intake.”
🔸 “We want to make sure engineers can be engineers again.”
🔸 “I think it’s primarily on the basis of the more robust view that they have when it comes to demand for AI, which seems to be more sustainable from their vantage point... That recognition has led some of our customers to really invest in capacity and gear up their plans for medium-term capacity expansion"
Títulos em alta
Principais criadores desta semana

